Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Summary
The purpose of this study is to evaluate the effect of GW906 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of GW906.
Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of GW906 (SAL0132) Injection in Patients With Essential Hypertension
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
319
Start Date
2025-12-24
Completion Date
2026-09-15
Last Updated
2026-09-23
Healthy Volunteers
No
Conditions
Interventions
GW906
Subcutaneous injection
Placebo
Subcutaneous injection
Locations (1)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China
Shanghai, Shanghai Municipality, China